Skip to main content

Table 1 Outcome and mortality rates with regard to HIV status, irrespective of HTLV-I status.

From: Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau

  Negative HIV-1 HIV-2 HIV-1 + HIV-2 dual Total
  Men Women Men Women Men Women Men Women All
Previous HIV result from 1987, 1989, 1990, 1992, 1994 or 1996. 1,250 1,260 10 12 156 243 5 8 2,944
Total re-identified 1,247 1,259 10 12 156 243 5 8 2,940
Confusion/age uncertain 1/0 4/0 0/0 0/0 4/1 4/1 0/0 0/0 13/2
Exit study at age <35. 37 43 0 0 2 4 0 0 86
Total participating in analysis: 1,209 1,212 10 12 149 234 5 8 2,839
Seroconvert during follow-up time 7 9    2 3    
(status after sero-conversion) (2 HIV-1, 4 HIV-2 1 HIV-1/2) (HIV-2)    (HIV-1/2) (HIV-1/2)    
Moved (%*) 198 (16.5) 212 (17.6) 4 (33.3) 1 (8.3) 23 (15.2) 51(21.3) 4 (50) 2 (18.2) 495 (17.4)
Died (%*) 229 (19.1) 171 (14.2) 4 (33.3) 3 (25) 42 (27.8) 63 (26.3) 2 (25) 3 (27.3) 517 (18.2)
Median follow-up time in years 3.8 3.9 2.5 3.1 3.8 3.7 3.2 2.6 3.8
(range) (0.0–12.1) (0.0–12.4) (0.2–4.3) (0.4–3.8) (0.1–11.6) (0.1–12.0) (0.3–5.9) (0.6,4.5) (0.0–12.4)
Total follow-up time, years 5084 5398 26.9 33.6 648 1039 23.7 29.7 12283
Mortality rate/1000 pyo 45.0 31.7 149 89.3 64.8 60.6 84.3 101 42.1
(95% CI†) (39.5,51.3) (27.3, 36.8) (55.9, 397) (28.8, 278) (47.9, 87.7) (47.3,77.6) (21.1, 337) (32.6, 313) (38.6, 45.9)
  1. Individuals in general urban population cohorts in Guinea-Bissau with an HIV result from any previous survey during 1987–1996 were included in the study. The table shows the outcome of the eligible individuals according to HIV status. Some individuals changed HIV status during follow-up, from HIV-negative to HIV-1 and/or HIV-2-positive, or from HIV-2 to HIV-1/HIV-2 dually positive. This is shown in the middle section of the table. *% of total number participating according to current HIV status. †CI = confidence interval